Provider MAT Waiver Training

The University of Colorado Department of Family Medicine is collaborating with the Colorado Health Extension System (CHES), and the Implementing Technology and Medication Assisted Treatment and Team Training in Rural Colorado (IT MATTTRs Colorado) project to help address the opioid epidemic affecting our state. This is a response to calls from our healthcare communities for help in diagnosing opioid use disorders (OUD) and supporting patients in medication assisted treatment (MAT) programs. With funding provided by the Office of Behavioral Health, we are recruiting 700 providers to complete the MAT waiver training to become certified to prescribe medication for the treatment of OUD. In addition, we will provide support through tools, resources and team training to practice staff on implementing MAT programs.

*Please note: We have reached our compensation capacity with our current funds. Any new applications at this point will be placed on a waiting list. If our program is granted any new funding, you will be contacted. Providers who have done in person training or were part of a practice facilitation will be paid first on the wait list.  There are waiver trainings scheduled for 2020.

Who is Eligible?

Providers and providers in training which include physicians, nurse practitioners, and physician assistants are all eligible to complete the buprenorphine waiver training. Physicians require 8 hours of MAT training; NPs, CNSs, CNMs, CRNAs, and PAs require 24 hours of MAT training. Only providers who have completed the training after May 1st, 2017 are eligible for compensation.

  • MDs, DOs, and Residents: $300
  • NPs, PAs, CNSs, CNMs, and CRNAs: $500

*Please note that we currently have a wait list for compensation. If more compensation is provided the wait list will be paid out at a first come first serve basis.  The training is still offered for free.

Get Trained

Providers can complete 100% of your training online, or complete a hybrid training where the first half is a 4.25-hour training in person with 3.75 hours online. Check back periodically for additional in-person training dates.

For CME Information Click Here

Option One- HYBRID - Part in person, Part on-line

Alamosa

Who: Aimee Techau and Dr. Lesley Brooks

Where: .  Valley-Wide Health Systems Administrative Services Building, 128 Market St. Alamosa, Colorado 81101: Training Rooms 1 and 2.

When: Friday, February 28th, 2020 Time: TBD

How: Register Here! 

 

The American Academy of Addiction Psychiatry is the sponsoring data organization for these trainings. Funding for these courses were made possible (in part) by 1U79TI026556 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government CME Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAP and University of Colorado Denver. AAAP is accredited by the ACCME to provide continuing medical education for physicians. .
Option Two – Online Training Options

  • Submit Your Application for your Waiver Here: http://buprenorphine.samhsa.gov/forms/select-practitioner-type.php
    • Upon completion of the MAT waiver training, providers must apply for a waiver through the Drug Enforcement Agency (DEA) to prescribe buprenorphine.  You will need the following information:
      • All will need a Certificate of Completion for the 8 hour MAT training.
      • NPs, PAs, CNSs, CNMs, and CRNAs will need a Certificate of Completion for the additional 16-hour training required.
    • The waiver applications are forwarded to the DEA, which assigns the prescriber a special identification number.  The DEA regulations require that this number, and the provider's regular DEA registration number, be included on all buprenorphine prescriptions.
    • The application process takes about 45 days.  If the application is approved, the provider will receive a letter that confirms their waiver and contains the new buprenorphine prescribing identification number. Prescribers are capped at 30 MAT patients for the first year. After the first year of being limited to 30 patients you can apply online to increase to 100 patients, and a year after that you can apply again to increase to up to 275 patients at any one time. 
    • Residents won’t actually complete their Notice of Intent (NOI) form until they have their unrestricted DEA license.  At the conclusion of the training, they will get a survey which will generate their certificate.  They should hold on to this certificate and then when it’s time to apply for their waiver they can submit it with their NOI form. Residents may apply for the remaining $240 Waiver incentive within 3 months of completing their training.

*Please note: We have reached our compensation capacity with our current funds. Any new applications at this point will be placed on a waiting list. If our program is granted any new funding, you will be contacted.

  • Fill out your information and upload a copy of your certificate of completion for compensation. After you complete the form, you will be sent an email within 14 business days from the University of Colorado to complete your w-9. Step-by-step instructions will be included.

LINK TO COMPENSATION FORM

Click Here to Complete your Follow Up Survey

Who is eligible? Any practice in the state of Colorado that has at least one provider with a waiver to prescribe buprenorphine. Each practice must commit to having all staff receive the 5 hours of training on the IT MATTTRs Curriculum.

Please fill out an interest form and we will contact you to schedule your practice facilitation.

IT MATTTRs 2 PRACTICE INTEREST FORM